Docoh
Loading...

213 results

Filter options loading...
Top filers
Top filing types
Recent filing years
DEF 14A
PRPO Precipio Inc
29 Apr 21
Definitive proxy
4:31pm
. LaPorte is an executive and venture capital investor with 30 years’ experience building innovative life sciences companies. Ms. LaPorte served
424B5
PRPO Precipio Inc
2 Apr 21
Prospectus supplement for primary offering
2:00pm
but of developing innovative products to mitigate misdiagnoses. Further, our platform enables our commercial lab to be utilized as an incubator for the development … are the only company focused on addressing the issue of diagnostic accuracy with an innovative, robust and scalable business model by: Providing
10-K
2020 FY
PRPO Precipio Inc
29 Mar 21
Annual report
4:29pm
with the mission of not only providing the highest quality pathology testing services but of developing innovative products to mitigate misdiagnoses … with access to these innovative technologies developed by us and in collaboration with other academic institutions we engage with. Government
424B3
PRPO Precipio Inc
7 Jul 20
Prospectus supplement
5:27pm
with an innovative, robust and scalable business model by: Providing physicians and their patients access to world-class academic experts
S-1
PRPO Precipio Inc
26 Jun 20
IPO registration
5:18pm
. To our knowledge, we are the only company focused on addressing the issue of diagnostic accuracy with an innovative, robust and scalable business
DEF 14A
PRPO Precipio Inc
29 Apr 20
Definitive proxy
4:32pm
and execution. Kathleen D. LaPorte Ms. LaPorte is an executive and venture capital investor with 30 years’ experience building innovative life sciences
424B3
PRPO Precipio Inc
13 Apr 20
Prospectus supplement
4:55pm
on addressing the issue of diagnostic accuracy with an innovative, robust and scalable business model by: Providing physicians and their patients access
S-3/A
PRPO Precipio Inc
9 Apr 20
Shelf registration (amended)
1:53pm
on addressing the issue of diagnostic accuracy with an innovative, robust and scalable business model by: Providing physicians and their patients access
S-1/A
PRPO Precipio Inc
8 Apr 20
IPO registration (amended)
3:41pm
on addressing the issue of diagnostic accuracy with an innovative, robust and scalable business model by: Providing physicians and their patients access
S-3
PRPO Precipio Inc
27 Mar 20
Shelf registration
4:51pm
of diagnostic accuracy with an innovative, robust and scalable business model by: Providing physicians and their patients access to world-class
S-1
PRPO Precipio Inc
27 Mar 20
IPO registration
4:31pm
of diagnostic accuracy with an innovative, robust and scalable business model by: Providing physicians and their patients access to world-class academic
10-K
2019 FY
PRPO Precipio Inc
27 Mar 20
Annual report
3:47pm
are the only company focused on addressing the issue of diagnostic accuracy with an innovative, robust and scalable business model by: Providing physicians … or commercial lab patients. Our platform provides all patients with access to these innovative technologies developed by us and in collaboration
424B3
PRPO Precipio Inc
30 Jan 20
Prospectus supplement
5:09pm
, we are the only company focused on addressing the issue of diagnostic accuracy with an innovative, robust and scalable business model by: Providing
S-1/A
PRPO Precipio Inc
27 Jan 20
IPO registration (amended)
4:47pm
focused on addressing the issue of diagnostic accuracy with an innovative, robust and scalable business model by: Providing physicians
S-1
PRPO Precipio Inc
14 Jan 20
IPO registration
4:26pm
accuracy with an innovative, robust and scalable business model by: Providing physicians and their patients access to world-class academic experts
8-K
EX-99.1
PRPO Precipio Inc
4 Dec 19
Precipio Announces the Resignation of Samuel Riccitelli and the Introduction of Richard Sandberg to its Board of Directors
4:01pm
brain injury. “I have always been intrigued with Precipio’s disruptive and innovative business model to improve the information available
424B3
PRPO Precipio Inc
21 Aug 19
Prospectus supplement
5:28pm
company focused on addressing the issue of diagnostic accuracy with an innovative, robust and scalable business model by: Providing physicians
S-1
PRPO Precipio Inc
9 Aug 19
IPO registration
3:47pm
diagnoses. To our knowledge, we are the only company focused on addressing the issue of diagnostic accuracy with an innovative, robust and scalable
DEF 14A
PRPO Precipio Inc
29 Apr 19
Definitive proxy
5:22pm
years’ experience building innovative life sciences companies. She served as general partner with Sprout Group from 1993-2005. Ms. LaPorte was one
10-K
2018 FY
PRPO Precipio Inc
16 Apr 19
Annual report
5:20pm
in order to better provide diagnoses. To our knowledge, we are the only company focused on addressing the issue of diagnostic accuracy with an innovative … internally and does not benefit outside or commercial lab patients. Our platform provides all patients with access to these innovative technologies